Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3

The mechanism of neurodegeneration in CAG/polyglutamine repeat expansion diseases is unknown but is thought to occur at the protein level. Here, in studies of spinocerebellar ataxia type 3, also known as Machado-Joseph disease (SCA3/MJD), we show that the disease protein ataxin-3 accumulates in ubiquitinated intranuclear inclusions selectively in neurons of affected brain regions. We further provide evidence in vitro for a model of disease in which an expanded polyglutamine-containing fragment recruits full-length protein into insoluble aggregates. Together with recent findings from transgenic models, our results suggest that intranuclear aggregation of the expanded protein is a unifying feature of CAG/polyglutamine diseases and may be initiated or catalyzed by a glutamine-containing fragment of the disease protein.

[1]  H. Green,et al.  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Zoghbi,et al.  Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.

[3]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[4]  L. Schöls,et al.  Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients. , 1995, Human molecular genetics.

[5]  K. Fischbeck,et al.  Machado‐Joseph disease gene product is a cytoplasmic protein widely expressed in brain , 1997, Annals of neurology.

[6]  P E Fraser,et al.  A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C A Ross,et al.  Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[9]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[10]  K. Fischbeck,et al.  Trinucleotide repeats in neurogenetic disorders. , 1996, Annual review of neuroscience.

[11]  R. Rosenberg.  Machado‐Joseph disease: An autosomal dominant motor system degeneration , 1992, Movement disorders : official journal of the Movement Disorder Society.

[12]  S. Tsuji,et al.  A clinical and pathologic study of a large Japanese family with Machado‐ Joseph disease tightly linked to the DNA markers on chromosome 14q , 1994, Neurology.

[13]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[14]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[15]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[16]  A. Roses,et al.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.

[17]  J. D. den Dunnen,et al.  Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. , 1996, Human molecular genetics.

[18]  G. Sobue,et al.  Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. , 1995, Human molecular genetics.

[19]  P. Coutinho,et al.  Machado-Joseph disease. , 1995, Clinical neuroscience.

[20]  H. Zoghbi,et al.  Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado‐Joseph disease , 1995, Annals of neurology.

[21]  P. Chambon,et al.  The N‐terminal domain of the human TATA‐binding protein plays a role in transcription from TATA‐containing RNA polymerase II and III promoters. , 1994, The EMBO journal.

[22]  Harry T Orr,et al.  SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat , 1995, Cell.

[23]  H. Ehrsson,et al.  An expanded CAG repeat sequence in spinocerebellar ataxia type 7. , 1996, Genome research.

[24]  Í. Lopes-Cendes,et al.  Correlation between CAG repeat length and clinical features in Machado-Joseph disease. , 1995, American journal of human genetics.

[25]  H. Zoghbi.  The expanding world of ataxins , 1996, Nature Genetics.

[26]  Yves Agid,et al.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats , 1996, Nature Genetics.

[27]  D. Housman.  Gain of glutamines, gain of function? , 1995, Nature Genetics.

[28]  J. Beckmann,et al.  The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. , 1994, Genomics.

[29]  H. Green.  Human genetic diseases due to codon reiteration: Relationship to an evolutionary mechanism , 1993, Cell.

[30]  M. Perutz,et al.  Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. , 1996, Current opinion in structural biology.

[31]  M. MacDonald,et al.  Huntingtin Immunoreactivity in the Rat Neostriatum: Differential Accumulation in Projection and Interneurons , 1997, Experimental Neurology.

[32]  C A Ross,et al.  When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases , 1995, Neuron.

[33]  H. Lehrach,et al.  HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. , 1997, Human molecular genetics.

[34]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[35]  T. Yuasa,et al.  Joseph's disease: Clinical and pathological studies in a Japanese family , 1986, Annals of neurology.

[36]  E. Hirsch,et al.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.

[37]  E. Mengual,et al.  Immunohistochemical Distribution and Electron Microscopic Subcellular Localization of the Proteasome in the Rat CNS , 1996, The Journal of Neuroscience.

[38]  J. Hodgson,et al.  Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme* , 1996, The Journal of Biological Chemistry.

[39]  M. MacDonald,et al.  Huntington's disease: translating a CAG repeat into a pathogenic mechanism , 1996, Current Opinion in Neurobiology.

[40]  G. Auburger,et al.  Autosomal dominant cerebellar ataxia , 1990, Neurology.

[41]  I. Kanazawa,et al.  HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain , 1997, Nature Genetics.

[42]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[44]  M. Perutz,et al.  Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Matt L. Huffman,et al.  When More is Less , 1997 .

[46]  A. Sano,et al.  Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p , 1994, Nature Genetics.

[47]  D. Dickson,et al.  Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[48]  S. Prusiner,et al.  Etiology and pathogenesis of prion diseases. , 1995, The American journal of pathology.

[49]  L. Forno,et al.  Joseph disease , 1982, Neurology.

[50]  S. Narumiya,et al.  Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo , 1996, Nature Genetics.

[51]  T D Bird,et al.  Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. , 1995, American journal of human genetics.

[52]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[53]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.

[54]  M. Hayden,et al.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract , 1996, Nature Genetics.

[55]  A. Korczyn,et al.  Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews , 1996, Neurology.

[56]  D W Dickson,et al.  Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. , 1995, Clinical neuropathology.

[57]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.

[58]  S. Hersch,et al.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Tsuji,et al.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT , 1996, Nature Genetics.

[60]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[61]  G. Bates.  Expanded glutamines and neurodegeneration--a gain of insight. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[62]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[63]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[64]  R. Mayer,et al.  Ubiquitin in Neurodegenerative Diseases , 1993, Brain pathology.

[65]  J. Palo,et al.  Neurofilament subunit–related proteins in neuronal intranuclear inclusions , 1984, Annals of neurology.

[66]  Alexandra Durr,et al.  Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular, and neuropathological features , 1996, Annals of neurology.